Synapse - Works

Results (13087)

LPAM (Alpha4 Beta7 integrin) is an important homing integrin on alloreactive T cells in the development of intestinal graft-versus-host disease but not graft-versus-tumor effect

Meeting Abstract

Kirovski, A.; Feinman, J. W.; Alpdogan, O.; Willis, L. M.; Eng, J.; Kartono, T. H.; van den Brink, M. R. M.
Blood (2002)

Fulltext@MSK | Save

An analysis of accelerated full course chemotherapy followed by upfront high dose therapy (HDT) and autologous stem cell transplantation (ASCT) for patients with International Prognostic Index IV (IPI IV) aggressive NHL

Meeting Abstract

Moskowitz, C. H.; Kewalramani, T.; Donnelly, G.; Zelenetz, A. D.; Noy, A.; Rice, D.; Kuznetsov, M.; Straus, D.; Nimer, S. D.; Portlock, C. S.
Blood (2002)

Fulltext@MSK | Save

Similar outcomes for chemosensitive (CS) relapsed or primary refractory peripheral T-cell lymphoma (PTCL) and diffuse large B-cell lymphoma (DLBCL) treated with autologous transplantation (ASCT)

Meeting Abstract

Kewalramani, T.; Nimer, S. D.; Zelenetz, A. D.; Hamlin, P. A.; Horwitz, S.; Qin, J.; Malhotra, S.; Yahalom, J.; Moskowitz, C. H.
Blood (2002)

Fulltext@MSK | Save

High-resolution DNA typing for HLA-A, -B, and -DRB1 has direct impact on the survival in the recipients of unrelated donor (URD) hematopoietic stem cell transplant (HSCT)

Meeting Abstract

Prasad, V.; Kernan, N. A.; Heller, G.; Boulad, F.; Castro-Malaspina, H.; Jakubowski, A.; Papadopoulos, E.; Perales, M.; Small, T. N.; Van Den Brink, M.; more...
Blood (2002)

Fulltext@MSK | Save

Intravenous busulfan and melphalan followed by an unmodified related or unrelated hematopoietic stem cell transplant for the treatment of advanced hematologic malignancies

Meeting Abstract

Papadopoulos, E. B.; Boulad, F.; Castro-Malaspina, H.; Jakubowski, A. A.; Kernan, N. A.; Perales, M. A.; Prasad, V.; Young, J. W.; Van Den Brink, M.; Toomasi, F.; more...
Blood (2002)

Fulltext@MSK | Save

Gemicitabine/vinorelbine - A well tolerated and effective regimen for patients with relapsed/refractory Hodgkin's disease (RD) who fail autologous stem cell transplantation (ASCT)

Meeting Abstract

Hamlin, P. A.; Kewalramani, T.; Schaindlin, P.; Moskowitz, C. H.
Blood (2002)

Fulltext@MSK | Save

Ig V-H and V-L patient-specific PCR: Assessing clonotypic contamination in stem cell components (SCC) mobilized with melphalan in myeloma

Meeting Abstract

Zhou, P.; Zhang, Y.; Martinez, C.; Kalakonda, N.; Nimer, S. D.; Comenzo, R. L.
Blood (2002)

Fulltext@MSK | Save

Human lymphocytes sensitized to HLA A0201 and HLA A2402 binding WT-1 peptides loaded on autologous cytokine activated monocytes or EBV transformed B cells yield HLA restricted WT-1 peptide specific cytotoxic T cells that lyse primary WT-1+leukemic cells in vitro and, in vivo, home to and induced regression of WT-1+leukemic xenografts bearing the restricting HLA alleles

Meeting Abstract

Doubrovina, E.; Guerrero, J.; Lee, S. Y.; Koehne, G.; Doubrovin, M.; Diaz-Barrientos, T.; O'Reilly, R. J.
Blood (2002)

Fulltext@MSK | Save

Xenogeneic DNA immunization against CD20 elicits immune responses and confers modest tumor protection in a mouse model of lymphoma

Meeting Abstract

Palomba, M. L.; Roberts, W. K.; Scheinberg, D. A.; Houghton, A. N.
Blood (2002)

Fulltext@MSK | Save

In vivo anti-tumor activity of genetically modified T cells is dependent on the method of ex vivo T cell expansion

Meeting Abstract

Brentjens, R. J.; Latouche, J. B.; Riviere, I.; Sadelain, M.
Blood (2002)

Fulltext@MSK | Save